Colonial Trust’s Inspire Medical Systems INSP Stock Holding History

Colonial Trust’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-70	Closed	-$13K	–	1221
2024 Q4	$13K	Buy	+70	New	+$13.6K	﹤0.01%	902

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Colonial Trust's INSP Position: Q1 2025 in Review

Colonial Trust sold out of Inspire Medical Systems (INSP) in Q1 2025, closing a stake of 70 shares — an estimated $13K sold.

Colonial Trust first reported a position in INSP in Q4 2024 and held it in 1 quarter. The position peaked at $13K in Q4 2024. 363 funds tracked by Wall St. Rank hold INSP as of Q1 2025.

Colonial Trust reported no remaining Inspire Medical Systems position as of Q1 2025 after selling out during the quarter.
Colonial Trust sold 70 Inspire Medical Systems shares in Q1 2025, an estimated $13K.
Colonial Trust first reported a position in Inspire Medical Systems in Q4 2024 and held it in 1 quarter.
Colonial Trust's Inspire Medical Systems position peaked at $13K in Q4 2024.
363 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2025.

Based on Colonial Trust's 13F filing for Q1 2025, filed 14 May 2025.